← Eichor
Condition: Severe Aplastic Anemia Saa Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Severe Aplastic Anemia Saa

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Phase 2 · 1 location(s) · Mitchell Cairo · NCT04099966A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT07586735Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT05012111Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilic
Phase 1/Phase 2 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT03173937CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia
EARLY_Phase 1 · 1 location(s) · Zhejiang University · NCT06633328Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06695741Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03579875Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia
Phase 1/Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07714512Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells a
Phase 2 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT03520647HPC Offered for PRESERVE Expansion
Phase N/A · 4 location(s) · Ossium Health, Inc. · NCT07145411Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06613880CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia
Phase 1 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06622694Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic Anemia
Phase 2 · 1 location(s) · Hematology department of the 920th hospital · NCT06378060TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
Phase 2 · 1 location(s) · Johns Hopkins All Children's Hospital · NCT04356469Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Us
Phase 2 · 2 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT01174108Haploidentical HCT for Severe Aplastic Anemia
Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT04558736Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07010237Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
Phase 2 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT04304820Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
Phase 2 · 25 location(s) · Medical College of Wisconsin · NCT06517641Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
Phase 2 · 2 location(s) · Northside Hospital, Inc. · NCT02828592A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Phase N/A · 142 location(s) · Center for International Blood and Marrow Transplant Researc · NCT01351545A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploident
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT05757310Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06254560MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Se
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT06412497
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.